Manufacturers warn not to inject disinfectant to treat Covid-19, after President Trump's comments

The US president is facing a backlash after suggesting it would be ‘interesting to check’ whether a disinfectant injection could help combat coronavirus.

During his latest press conference, Mr Trump said researchers were looking at the effects of disinfectants on Covid-19.

Wondering aloud if they could be injected into people, he added the virus ‘does a tremendous number on the lungs, so it would be interesting to check that’.

But hours later, disinfectant manufacturer RB, the company behind the Dettol and Lysol brands, urged people not to try the method.

The company issued a statement saying: ‘Due to recent speculation and social media activity, RB has been asked whether internal administration of disinfectants may be appropriate for investigation or use as a treatment for coronavirus.

‘As a global leader in health and hygiene products, we must be clear that under no circumstance should our disinfectant products be administered into the human body (through injection, ingestion or any other route).’

SEE ALSO: Southampton children's nurse dies after testing positive for Covid-19

It added that all its products should only be used as intended and according to usage guidelines.

In response to the Mr Trump's comments, William Bryan of the Department of Homeland Security science and technology unit said health officials were not considering such treatment.

A message from the Editor

Thank you for reading this story on portsmouth.co.uk. While I have your attention, I also have an important request to make of you.

With the coronavirus lockdown having a major impact on many of our advertisers - and consequently the revenue we receive - we are more reliant than ever on you taking out a digital subscription.

Subscribe to portsmouth.co.uk and enjoy unlimited access to local news and information online and on our app. With a digital subscription, you can read more than 5 articles, see fewer ads, enjoy faster load times, and get access to exclusive newsletters and content. Visit our Subscription page now to sign up.

Our journalism costs money and we rely on advertising, print and digital revenues to help to support them. By supporting us, we are able to support you in providing trusted, fact-checked content for this website.